Ask The Pharmacist: Cosentyx and Its Place in Workers’ Comp
Are you seeing requests for Cosentyx for your injured employee but are unclear on the application of this medication? Cosentyx, a biologic medication developed by Novartis, is increasingly recognized in the treatment landscape for chronic autoimmune conditions such as plaque psoriasis, ankylosing spondylitis and psoriatic arthritis.
Demystifying the Nuances of Specialty Bill Review Regulations
Navigate the complexities of Specialty Bill Review Regulations with Enlyte. Tune into our podcast where Trevor Davis, our Director of Regulatory Affairs, offers insights into dispute management, regulatory changes, and our strategic efforts to shape the landscape.
Gauging the Impact of High-Impact Drugs in Workers’ Comp
An Overlooked Essential: Hospital Discharge Planning in Workers’ Compensation
In a recent article, Jim Begg, Vice President of National Accounts for Apricus, highlights the critical role of effective discharge planning in helping patients recover swiftly and safely.
Bridging the Gap for New Adjusters with Innovative Tools
Streamline your claims process and support your team with our cutting-edge solutions.
New Trends in Opioids and Pain Management
Despite decreases in utilization and cost per claim, opioids remain the No. 1 drug class in Enlyte’s 2024 Drug Trends Report. However, due to concerns with safety and overutilization, increased focus on usage guidelines as well as alternatives to pain management are gaining momentum — including those whose active ingredients drive from things you might not imagine, like pufferfish, cacti and chili peppers. Enlyte’s Nikki Wilson explores this and more in our Part 3 drug trends analysis.
Ask The Pharmacist: GLP-1 Drugs in Workers’ Compensation
Glucagon-like peptide 1 (GLP-1) receptor agonists medications, originally designed for diabetes management, have skyrocketed in popularity over the past year as effective drugs for weight loss and obesity.